|
|
Inter-American Drug Abuse Control Commission (CICAD) |
|
PROJECTS |
| Area | Inter-American Observatory on Drugs (OID) / Research and Analysis |
| Project Name | The Human, Social and Economic Costs of Drugs in the Americas |
| Start
Date/ Duration |
May 2002-May 2005 |
| Location | Barbados, Chile, Costa Rica, El Salvador, Mexico, Uruguay |
| Beneficiaries | Barbados, Chile, Costa Rica, El Salvador, Mexico, Uruguay |
| Participating Institutions | The University of Medicine and Dentistry of New Jersey /Robert Wood Johnson Medical School; the Canadian Centre on Substance Abuse (CCSA), the Bureau for International Narcotics and Law Enforcement (INL) at the United States Department of State; the National Council on Substance Abuse (NCSA) of Barbados; the Consejo Nacional Contra Estupefacientes (CONACE) of Chile; the Instituto Costarricense sobre Drogas (ICD) and the Instituto sobre Alcoholismo y fármacodependencia of Costa Rica; la Comisión Salvadoreña Antidrogas (COSA), and La Fundación Antidrogas (FUNDASALVA) of El Salvador; Centro de Planeación para el Control de Drogas of Mexico; and La Junta Nacional de Drogas of Uruguay |
| Budget | US$1,000,000.00 |
| Donors | Government
of the United States of America
Government of Canada |
| Project Description |
The purpose of the Cost Program is to develop a
methodology that will provide a framework through which OAS member
states can measure the economic impact that drug use has on their
societies. Its primary goal
is to do this in a way that is both simple and economically feasible.
The strategy is to develop a series of inter-related projects
that will allow the countries to produce estimates on cost impact in a
variety of social sectors such as health, criminal justice, welfare,
industry, and labor enabling them to examine the impact of drugs in
scientifically valid terms and use that knowledge to formulate sound,
research-based policy. Armed
with specific cost data countries can then make rational decisions about
where to target scarce government resources.
More importantly, by understanding where money is being invested
and the costs related to those investments, decision makers can then
devise strategies to reduce those costs.
T Presently there are four pilot countries (Barbados, Costa Rica, Mexico and Uruguay) participating in the development of the CICAD methodology. he methodology is divided into a series of indicators stratified by level of difficulty. Each country must systematically gather and validate the data corresponding to each indicator in order to produce valid cost estimates. In addition there are two countries (Chile and El Salvador) who have committed themselves to following and testing the CICAD methodology that has been developed thus far. The impetus for this project began with
Recommendation 20 of CICAD’s Multilateral Evaluation Mechanism (MEM),
Hemispheric Report 1999-2000, and also the Summit of the Americas in
Quebec City in May of 2001, where CICAD received a mandate to “develop
within the framework of CICAD, a mechanism to measure to human, social
and economic costs of drug abuse.”
|
| Objectives |
By Fall 2004
By Spring 2005, Summit of the Americas:
|
| Links | Link
to the Cost Manual on the OID website
Link to the Cost Program data management page http://cicad.europe.webmatrixhosting.net/ |